These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 24332065)
1. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis. Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue. van Huizen NA; Coebergh van den Braak RRJ; Doukas M; Dekker LJM; IJzermans JNM; Luider TM J Biol Chem; 2019 Jan; 294(1):281-289. PubMed ID: 30409905 [TBL] [Abstract][Full Text] [Related]
3. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152 [TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC). Hammoudi A; Song F; Reed KR; Jenkins RE; Meniel VS; Watson AJ; Pritchard DM; Clarke AR; Jenkins JR Biochem Biophys Res Commun; 2013 Oct; 440(3):364-70. PubMed ID: 23998936 [TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis. Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784 [TBL] [Abstract][Full Text] [Related]
6. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry. Bai Y; Wang J; Gao Z; Dai E Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204 [TBL] [Abstract][Full Text] [Related]
7. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer. Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014 [TBL] [Abstract][Full Text] [Related]
8. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Yuan D; Li K; Zhu K; Yan R; Dang C Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978 [TBL] [Abstract][Full Text] [Related]
9. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach. Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854 [TBL] [Abstract][Full Text] [Related]
10. Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma. Wang XQ; Tang ZX; Yu D; Cui SJ; Jiang YH; Zhang Q; Wang J; Yang PY; Liu F Oncotarget; 2016 Feb; 7(8):8823-38. PubMed ID: 26741506 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients. Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835 [TBL] [Abstract][Full Text] [Related]
12. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry. Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392 [TBL] [Abstract][Full Text] [Related]
13. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry. Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013 [No Abstract] [Full Text] [Related]
14. Identification of Cystatin SN as a novel tumor marker for colorectal cancer. Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549 [TBL] [Abstract][Full Text] [Related]
15. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer. Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800 [TBL] [Abstract][Full Text] [Related]
16. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics. Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327 [TBL] [Abstract][Full Text] [Related]
17. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma. Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623 [TBL] [Abstract][Full Text] [Related]
18. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer. Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817 [TBL] [Abstract][Full Text] [Related]
19. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival. Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083 [TBL] [Abstract][Full Text] [Related]
20. Proteomic screening of potential N-glycoprotein biomarkers for colorectal cancer by TMT labeling combined with LC-MS/MS. Gong Q; Zhang X; Liang A; Huang S; Tian G; Yuan M; Ke Q; Cai Y; Yan B; Wang J; Wang J Clin Chim Acta; 2021 Oct; 521():122-130. PubMed ID: 34242638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]